Original Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2012; 18(48): 7251-7261
Published online Dec 28, 2012. doi: 10.3748/wjg.v18.i48.7251
Table 2 The correlation between the genotype of CDH17 gene c.343A>G and clinicopathologic parameters in colorectal carcinomas n (%)
Clinicopathologic parametersnGenotype CDH17 c.343A>Gχ2P value
A/AA/GG/G
Gender
Male4710 (21.3)25 (53.2)12 (25.5)2.2360.327
Female4616 (34.8)19 (41.3)11 (23.9)
Age (yr)
< 502910 (34.5)15 (51.7)4 (13.8)2.8540.240
≥ 506416 (25)29 (45.3)19 (29.7)
Tumor location
Colon328 (25.0)16 (50.0)8 (25.0)0.2290.892
Rectum6118 (29.5)28 (45.9)15 (24.6)
Tumor size (cm)
< 56818 (26.5)34 (50.0)16 (23.5)0.7340.693
≥ 5258 (32.0)10 (40.0)7 (28.0)
Macroscopic appearance
Protrude type318 (25.8)17 (54.8)6 (19.4)1.9480.7451
Ulcer type4612 (26.1)21 (45.7)13 (28.3)
Infiltrating type166 (37.5)6 (37.5)4 (25.0)
Colloid type00 (0.0)0 (0.0)0 (0.0)
Histologic type
Adenocarcinoma7118 (25.4)34 (47.9)19 (26.8)2.1790.7031
Adenocarcinoma and mucinous carcinoma94 (44.4)3 (33.3)2 (22.2)
Mucinous carcinoma134 (30.8)7 (53.8)2 (15.4)
Undifferentiated carcinoma00 (0.0)0 (0.0)0 (0.0)
Adenosquamous carcinoma00 (0.0)0 (0.0)0 (0.0)
Squamous cell carcinoma00 (0.0)0 (0.0)0 (0.0)
Invasion depth
Submucosa20 (0.0)2 (100.0)0 (0.0)0.6960.7062
Muscular layer3412 (35.3)15 (44.1)7 (20.6)
Serous coat4812 (25)21 (43.8)15 (31.3)
Other organs92 (22.2)6 (66.7)1 (11.1)
Differentiation degree
Well-differentiated40 (0.0)2 (50.0)2 (50.0)2.2120.3312
Moderately-differentiated6317 (27.0)33 (52.4)13 (20.6)
Poorly-differentiated269 (34.6)9 (34.6)8 (30.8)
Lymph node metastasis
No5916 (27.1)35 (59.3)8 (13.6)13.1050.0013
Yes3410 (29.4)9 (26.5)15 (44.1)
TNM grade
I268 (30.8)16 (61.5)2 (7.7)10.3440.00623
II317 (22.6)18 (58.1)6 (19.4)
III339 (27.3)9 (27.3)15 (45.5)
IV32 (66.7)1 (33.3)0 (0.0)
Hematogenous metastasis
No9024 (26.7)43 (47.8)23 (25.6)2.5560.2791
Yes32 (66.7)1 (33.3)0 (0.0)
Recurrence
No9124 (26.4)44 (48.4)23 (25.3)5.2670.0721
Yes22 (100.0)0 (0.0)0 (0.0)